Current status and prospects for gene therapy

被引:16
作者
Nathwani, AC
Benjamin, R
Nienhuis, AW
Davidoff, AM
机构
[1] UCL, Dept Haematol, London WC1E 6HX, England
[2] Natl Blood Serv, London, England
[3] St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA
关键词
gene therapy; oncoretroviral vectors; adenoviral vectors; AAV vectors;
D O I
10.1111/j.1423-0410.2004.00543.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy is a new and exciting therapeutic concept that offers the promise of cure for an array of inherited, malignant and infectious disorders. After years of failure, substantial progress in the efficiency of gene-transfer technology has recently resulted in impressive clinical success in infants with immunodeficiency. Two of these children have, however, subsequently developed leukaemia as a result of insertional mutagenesis, raising concerns about the safety of genetic therapeutics. The purpose of this article is to review the current status of gene therapy in light of recent successes and tragedies, and to consider the challenges faced by this relatively new field.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 45 条
  • [1] Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
    Balagué, C
    Zhou, JM
    Dai, YF
    Alemany, R
    Josephs, SF
    Andreason, G
    Hariharan, M
    Sethi, E
    Prokopenko, E
    Jan, HY
    Lou, YC
    Hubert-Leslie, D
    Ruiz, L
    Zhang, WW
    [J]. BLOOD, 2000, 95 (03) : 820 - 828
  • [2] GM-CSF-based cellular vaccines: a review of the clinical experience
    Borrello, I
    Pardoll, D
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 185 - 193
  • [3] The insulation of genes from external enhancers and silencing chromatin
    Burgess-Beusse, B
    Farrell, C
    Gaszner, M
    Litt, M
    Mutskov, V
    Recillas-Targa, F
    Simpson, M
    West, A
    Felsenfeld, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 : 16433 - 16437
  • [4] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
    Cavazzana-Calvo, M
    Hacein-Bey, S
    Basile, CD
    Gross, F
    Yvon, E
    Nusbaum, P
    Selz, F
    Hue, C
    Certain, S
    Casanova, JL
    Bousso, P
    Le Deist, F
    Fischer, A
    [J]. SCIENCE, 2000, 288 (5466) : 669 - 672
  • [5] The future of gene therapy
    Cavazzana-Calvo, M
    Thrasher, A
    Mavilio, F
    [J]. NATURE, 2004, 427 (6977) : 779 - 781
  • [6] Immune responses to adenovirus and adeno-associated virus in humans
    Chirmule, N
    Propert, KJ
    Magosin, SA
    Qian, Y
    Qian, R
    Wilson, JM
    [J]. GENE THERAPY, 1999, 6 (09) : 1574 - 1583
  • [7] Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
    Chuah, MKL
    Schiedner, G
    Thorrez, L
    Brown, B
    Johnston, M
    Gillijns, V
    Hertel, S
    Van Rooijen, N
    Lillicrap, D
    Collen, D
    VandenDriessche, T
    Kochanek, S
    [J]. BLOOD, 2003, 101 (05) : 1734 - 1743
  • [8] Gene therapy insertional mutagenesis insights
    Davé, UP
    Jenkins, NA
    Copeland, NG
    [J]. SCIENCE, 2004, 303 (5656) : 333 - 333
  • [9] Davidoff AM, 2002, CANCER RES, V62, P3077
  • [10] HELPER VIRUS-INDUCED T-CELL LYMPHOMA IN NONHUMAN-PRIMATES AFTER RETROVIRAL MEDIATED GENE-TRANSFER
    DONAHUE, RE
    KESSLER, SW
    BODINE, D
    MCDONAGH, K
    DUNBAR, C
    GOODMAN, S
    AGRICOLA, B
    BYRNE, E
    RAFFELD, M
    MOEN, R
    BACHER, J
    ZSEBO, KM
    NIENHUIS, AW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1125 - 1135